Andrew Saik, CFO of Arvinas, Inc. ($ARVN), made two open market sales of company stock over the last year, totaling about $104,400. His most recent sale occurred on February 13, 2026. These transactions rank 9,510th out of 11,678 insiders in our database, well below the average sale value of 8.6 million and 6.4 transactions per seller. Saik reported no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 26, 2026 | ARVINAS, INC. | $ARVN | Saik Andrew | Chief Financial Officer | A | Stock Option (right to buy) | 67000 | $0.00 | 67,000.0000 | 73,400,000 | 9999.99% | 0.09% |
| Feb. 26, 2026 | ARVINAS, INC. | $ARVN | Saik Andrew | Chief Financial Officer | A | Common Stock | 45000 | $0.00 | 204,267.0000 | 73,400,000 | 28.25% | 0.06% |
| Feb. 13, 2026 | ARVINAS, INC. | $ARVN | Saik Andrew | Chief Financial Officer | S | Common Stock | 5134 | $11.89 | 159,267.0000 | 73,400,000 | 3.12% | 0.01% |
| June 24, 2025 | ARVINAS, INC. | $ARVN | Saik Andrew | Chief Financial Officer | S | Common Stock | 5700 | $7.61 | 164,401.0000 | 68,800,000 | 3.35% | 0.01% |
| June 10, 2025 | Milestone Pharmaceuticals Inc. | $MIST | Saik Andrew | Not found | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 53,464,273 | 9999.99% | 0.07% |
| May 9, 2025 | ARVINAS, INC. | $ARVN | Saik Andrew | Chief Financial Officer | A | Common Stock | 59600 | $0.00 | 170,101.0000 | 68,800,000 | 53.94% | 0.09% |
| May 9, 2025 | ARVINAS, INC. | $ARVN | Saik Andrew | Chief Financial Officer | A | Stock Option (right to buy) | 91000 | $0.00 | 91,000.0000 | 68,800,000 | 9999.99% | 0.13% |
| Feb. 13, 2025 | ARVINAS, INC. | $ARVN | Saik Andrew | Chief Financial Officer | A | Common Stock | 49092 | $0.00 | 110,501.0000 | 68,800,000 | 79.94% | 0.07% |
| Feb. 13, 2025 | ARVINAS, INC. | $ARVN | Saik Andrew | Chief Financial Officer | A | Stock Option (right to buy) | 74960 | $0.00 | 74,960.0000 | 68,800,000 | 9999.99% | 0.11% |
| Aug. 28, 2024 | Milestone Pharmaceuticals Inc. | $MIST | Saik Andrew | Not found | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 53,269,565 | 9999.99% | 0.08% |
| July 15, 2024 | Milestone Pharmaceuticals Inc. | $MIST | Saik Andrew | Not found | A | Stock Option (right to buy) | 80000 | $0.00 | 80,000.0000 | 53,260,467 | 50.00% | 0.15% |
| June 24, 2024 | ARVINAS, INC. | $ARVN | Saik Andrew | Chief Financial Officer | A | Stock Option (right to buy) | 94418 | $0.00 | 94,418.0000 | 68,000,000 | 9999.99% | 0.14% |
| June 24, 2024 | ARVINAS, INC. | $ARVN | Saik Andrew | Chief Financial Officer | A | Common Stock | 61409 | $0.00 | 61,409.0000 | 68,000,000 | 9999.99% | 0.09% |